跳至主要内容
临床试验/NCT00096421
NCT00096421已完成3 期

Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit: A Randomized Study

Hospital Pablo Tobón Uribe2 个研究点 分布在 1 个国家目标入组 504 人开始时间: 2003年7月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
504
试验地点
2
主要终点
Mortality in the next 28 days

研究概览

简要总结

The purpose of this study is to evaluate the impact of tight control of serum glucose levels with an intensive insulin treatment in patients hospitalized in an intensive care unit with medical and surgical patients.

详细描述

Reduction of morbidity-mortality in critical care patients with tight glycemic control had been proven in surgical patients only.

Study Hypothesis: In critical care patients, medical or surgical, a glucose serum level between 80 - 110 mg/dL means a lower mortality than patients with glucose levels of more than 110 mg/dL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 15 years of age or older,
  • Probability of staying in critical care for more than 48 hours,
  • Agreement with the informed consent.

排除标准

  • Pregnancy,
  • Participating in other trials,
  • Diabetic keto-acidosis or diabetic hyperosmolar state,
  • Do-not-resuscitate orders,
  • Reentry to the critical care unit of the same patient.

结局指标

主要结局

Mortality in the next 28 days

次要结局

  • Days of ventilatory support
  • Acute renal failure requiring dialysis or hemofiltration
  • Mortality during intensive care
  • Mortality overall in-hospital
  • Mortality among patients who remained in the intensive care unit for more than five days
  • Infections incidence in the critical care unit: nosocomial pneumonia, urinary tract infection and catheter related infection
  • Length of stay in the unit
  • The median number of red-cell transfusions
  • SOFA score
  • Critical-illness polyneuropathy

研究者

发起方
Hospital Pablo Tobón Uribe
申办方类型
Other

研究点 (2)

Loading locations...

相似试验